Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Development partner sought for new wound dressing

Feb. 12, 1997

Teva presents potential antipsoriatic agents

Feb. 12, 1997

Tretinoin gel cleared for marketing by FDA

Feb. 11, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Hyal's Solarase submitted for approval

Feb. 5, 1997

Bone morphogenic protein-10 claimed by Human Genome Sciences

Feb. 5, 1997

Patent coverage sought for novel approach to reducing side effects of vitamin A

Feb. 4, 1997

Allergan continues research into retinoids and retinoid-like compounds

Feb. 3, 1997

Preclinical results support Pharmadigm's DHEA development program

Jan. 31, 1997

Pierre Fabre to market Penederm OTC product

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026